Dassault Systemes in talks to buy drug trial software firm ArisGlobal, FT reports
· CNA · JoinRead a summary of this article on FAST.
Get bite-sized news via a new
cards interface. Give it a try.
Click here to return to FAST Tap here to return to FAST
FAST
July 16 : French software maker Dassault Systemes is in talks to buy drug-trial software maker ArisGlobal from Nordic Capital for about $2 billion, the Financial Times reported on Thursday, citing people familiar with the matter.
• The potential deal would extend Dassault Systemes' foray into software used in life sciences and would rank as its second-biggest acquisition after its $5.8 billion takeover of clinical trial software group Medidata Solutions in 2019, the report said.
• A transaction between the two firms is not a foregone conclusion, and talks could still fall apart, FT said.
• Reuters could not immediately verify the report.
CNA Games
Guess Word
Crack the word, one row at a time
Buzzword
Create words using the given letters
Mini Sudoku
Tiny puzzle, mighty brain teaser
Mini Crossword
Small grid, big challenge
Word Search
Spot as many words as you can
Show More
Show Less
• In April, Dassault Systemes reported first-quarter revenue of 1.51 billion euros ($1.77 billion), in line with estimates.
• Hit by a prolonged slowdown in the global auto industry, Dassault Systemes, which provides software to automakers, plane manufacturers and industrial firms, is increasingly tapping augmented AI and data centers to drive growth.
• Dassault Systemes, ArisGlobal and Nordic Capital could not immediately be reached for comment.
Newsletter
Week in Review
Subscribe to our Chief Editor’s Week in Review
Our chief editor shares analysis and picks of the week's biggest news every Saturday.
Sign up for our newsletters
Get our pick of top stories and thought-provoking articles in your inbox
Get the CNA app
Stay updated with notifications for breaking news and our best stories
Get WhatsApp alerts
Join our channel for the top reads for the day on your preferred chat app